Cargando…

Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy

OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Mhatre, Radhika, Sekar, Deepha, Ponmalar, Jessiena, Nagappa, Madhu, Veeramani, Preethish-Kumar, Polavarapu, Kiran, Vengalil, Seena, Atchayaram, Nalini, Narayanappa, Gayathri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232506/
https://www.ncbi.nlm.nih.gov/pubmed/34220063
http://dx.doi.org/10.4103/aian.AIAN_18_20
_version_ 1783713651633422336
author Mhatre, Radhika
Sekar, Deepha
Ponmalar, Jessiena
Nagappa, Madhu
Veeramani, Preethish-Kumar
Polavarapu, Kiran
Vengalil, Seena
Atchayaram, Nalini
Narayanappa, Gayathri
author_facet Mhatre, Radhika
Sekar, Deepha
Ponmalar, Jessiena
Nagappa, Madhu
Veeramani, Preethish-Kumar
Polavarapu, Kiran
Vengalil, Seena
Atchayaram, Nalini
Narayanappa, Gayathri
author_sort Mhatre, Radhika
collection PubMed
description OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (α2, α5,β1,γ1), Collagen-VI (A1,2,3), and Western blot (WB) for α-dystroglycan and POMT1 was performed. RESULTS: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-α2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-β1, over-expression of laminin-α5, and preserved laminin-γ1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for α-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-α2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker–Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. CONCLUSION: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis.
format Online
Article
Text
id pubmed-8232506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-82325062021-07-02 Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy Mhatre, Radhika Sekar, Deepha Ponmalar, Jessiena Nagappa, Madhu Veeramani, Preethish-Kumar Polavarapu, Kiran Vengalil, Seena Atchayaram, Nalini Narayanappa, Gayathri Ann Indian Acad Neurol Original Article OBJECTIVE: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. MATERIALS AND METHODS: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (α2, α5,β1,γ1), Collagen-VI (A1,2,3), and Western blot (WB) for α-dystroglycan and POMT1 was performed. RESULTS: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-α2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-β1, over-expression of laminin-α5, and preserved laminin-γ1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for α-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-α2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker–Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. CONCLUSION: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis. Wolters Kluwer - Medknow 2021 2020-07-24 /pmc/articles/PMC8232506/ /pubmed/34220063 http://dx.doi.org/10.4103/aian.AIAN_18_20 Text en Copyright: © 2006 - 2021 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mhatre, Radhika
Sekar, Deepha
Ponmalar, Jessiena
Nagappa, Madhu
Veeramani, Preethish-Kumar
Polavarapu, Kiran
Vengalil, Seena
Atchayaram, Nalini
Narayanappa, Gayathri
Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title_full Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title_fullStr Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title_full_unstemmed Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title_short Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy
title_sort utility of immunohistochemistry and western blot in profiling clinically suspected cases of congenital muscular dystrophy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232506/
https://www.ncbi.nlm.nih.gov/pubmed/34220063
http://dx.doi.org/10.4103/aian.AIAN_18_20
work_keys_str_mv AT mhatreradhika utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT sekardeepha utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT ponmalarjessiena utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT nagappamadhu utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT veeramanipreethishkumar utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT polavarapukiran utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT vengalilseena utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT atchayaramnalini utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy
AT narayanappagayathri utilityofimmunohistochemistryandwesternblotinprofilingclinicallysuspectedcasesofcongenitalmusculardystrophy